(Q39675249)

13 September 2017

title

Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin (English)

1 reference

13 September 2017

1 reference

0 references

Alexander M Scherbakov

1

1 reference

13 September 2017

Yulia S Lobanova

2

1 reference

13 September 2017

Olga E Andreeva

3

1 reference

13 September 2017

Valentina A Shatskaya

4

1 reference

13 September 2017

Mikhail A Krasil'nikov

5

1 reference

13 September 2017

publication date

1 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

31

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

137-143

1 reference

New approaches to the understanding of tamoxifen action and resistance

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

NF-kappaB suppression provokes the sensitization of hormone-resistant breast cancer cells to estrogen apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

The role of phosphatidylinositol 3-kinase in the regulation of cell response to steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Antioxidant responses to chronic hypoxia in the rat cerebellum and pons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Crossroads of estrogen receptor and NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100052

21 January 2018

Identifiers

DOI

10.1042/BSR20100052

1 reference

13 September 2017

1 reference